Off-Label Coverage of High-Cost Drugs by Independent Charity Patient Assistance Programs

J Gen Intern Med. 2021 Feb;36(2):555-556. doi: 10.1007/s11606-020-05682-9. Epub 2020 Feb 24.

Authors

So-Yeon Kang¹, Mariana P Socal², Ge Bai^{2

3}, Gerard F Anderson²

Affiliations

¹ Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. skang57@jhu.edu.
² Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
³ Johns Hopkins Carey Business School, Bernstein-Offit Building 353, 1717 Massachusetts Ave NW, Washington, DC, 20036, USA.

PMID: 32096083
PMCID: PMC7878656 (available on 2022-02-01)
DOI: 10.1007/s11606-020-05682-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Charities
Drug Costs
Humans
Insurance Coverage
Off-Label Use*
Pharmaceutical Preparations*

Substances

Pharmaceutical Preparations